Changes of Transforming Growth Factor b1 and Procollagen III in Patients With Acute Respiratory Distress Syndrome

计划入组 80 人 · 首次发布于 2007 年 2 月 27 日

Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease

计划入组 114 人 · 首次发布于 2020 年 6 月 5 日

Platelet Activation Markers in Pediatric Cardiac Surgery

计划入组 10 人 · 首次发布于 2007 年 3 月 21 日

NM-9308

TA-106

factor B inhibitor (age-related macular degeneration)

MAGNESIUM FACTOR PTY LTD

Australia

AB&B BIO-TECH-B

MOTHER SUN PROTECTION FACTOR PTY LTD

Australia

Nuvectis In-Licenses Two Clinical-Stage Assets from Haisco, Transforming into Late-Stage Biopharma with Oral Factor B and Paradox-Breaker BRAF Inhibitors

FDA Approves Fabhalta (Iptacopan) as First Oral Monotherapy for PNH

ADARx Pharmaceuticals to Present Phase 1 Data for ADX-038 siRNA Therapy at ASN Kidney Week 2025